title: What if the FDA had launched its action plan to close the health disparities gap for women two decades earlier?
authors.affiliation: Professor of Medicine (Cardiology), Emory University School of Medicine, Consultant, Emory Heart and Vascular Center, Atlanta, GA. Electronic address: nwenger@emory.edu.
authors.forename: Nanette K
authors.initials: NK
authors.lastname: Wenger
mesh_terms: D050197:Atherosclerosis / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood*; D005260:Female; D017408:Guidelines as Topic; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D011322:Primary Prevention / Q000379:methods*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol